Intranasal drug delivery: how, why and what for?
- PMID: 20067706
- DOI: 10.18433/j3nc79
Intranasal drug delivery: how, why and what for?
Abstract
Over the recent decades the interest in intranasal delivery as a non-invasive route for drugs is increased.Since the nasal mucosa offers numerous benefits as a target tissue for drug delivery, a wide variety of therapeutic compounds may be administered intranasally for topic, systemic and central nervous system action. We have, herein, outlined the relevant aspects of nasal anatomy, physiology and histology, and the biological, physicochemical and pharmaceutical factors that must be considered during the process of discovery and development of nasal drugs as well as in their incorporation into appropriate nasal pharmaceutical formulations.
Similar articles
-
Intranasal drug delivery: an efficient and non-invasive route for systemic administration: focus on opioids.Pharmacol Ther. 2012 Jun;134(3):366-79. doi: 10.1016/j.pharmthera.2012.03.003. Epub 2012 Mar 23. Pharmacol Ther. 2012. PMID: 22465159 Review.
-
Nasal drug delivery in humans.Curr Probl Dermatol. 2011;40:20-35. doi: 10.1159/000321044. Epub 2011 Feb 10. Curr Probl Dermatol. 2011. PMID: 21325837 Review.
-
Drug-metabolizing Enzymes and Efflux Transporters in Nasal Epithelium: Influence on the Bioavailability of Intranasally Administered Drugs.Curr Drug Metab. 2016;17(7):628-47. doi: 10.2174/1389200217666160406120509. Curr Drug Metab. 2016. PMID: 27048181 Review.
-
Factors affecting nasal drug delivery and design strategies for intranasal drug delivery.Zhejiang Da Xue Xue Bao Yi Xue Ban. 2023 Jun 25;52(3):328-337. doi: 10.3724/zdxbyxb-2023-0069. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2023. PMID: 37476944 Free PMC article. Review. Chinese, English.
-
Recent trends in drug delivery systems: intranasal drug delivery.Indian J Exp Biol. 1999 Jan;37(1):6-16. Indian J Exp Biol. 1999. PMID: 10355359 Review.
Cited by
-
Topical Drug Delivery for Chronic Rhinosinusitis.Curr Otorhinolaryngol Rep. 2013 Mar 1;1(1):51-60. doi: 10.1007/s40136-012-0003-4. Epub 2012 Dec 27. Curr Otorhinolaryngol Rep. 2013. PMID: 23525506 Free PMC article.
-
Nose-to-Heart Approach: Unveiling an Alternative Route of Acute Treatment.Biomedicines. 2024 Jan 16;12(1):198. doi: 10.3390/biomedicines12010198. Biomedicines. 2024. PMID: 38255302 Free PMC article. Review.
-
The novel peptide LCGM-10 attenuates metabotropic glutamate receptor 5 activity and demonstrates behavioral effects in animal models.Front Behav Neurosci. 2024 Feb 7;18:1333258. doi: 10.3389/fnbeh.2024.1333258. eCollection 2024. Front Behav Neurosci. 2024. PMID: 38385004 Free PMC article.
-
Repositioning of drugs for Parkinson's disease and pharmaceutical nanotechnology tools for their optimization.J Nanobiotechnology. 2022 Sep 15;20(1):413. doi: 10.1186/s12951-022-01612-5. J Nanobiotechnology. 2022. PMID: 36109747 Free PMC article. Review.
-
Challenges and Opportunities of Deferoxamine Delivery for Treatment of Alzheimer's Disease, Parkinson's Disease, and Intracerebral Hemorrhage.Mol Pharm. 2021 Feb 1;18(2):593-609. doi: 10.1021/acs.molpharmaceut.0c00474. Epub 2020 Oct 9. Mol Pharm. 2021. PMID: 32926630 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical